Screening of Cancer Through Novel Female Specific Biomarkers
common.study.values.description
“Screening of Cancer Through Novel Female Specific Biomarkers”
Can reliable biomarkers be identified for detection of cancer at early stages using menstrual blood (MB)? Preliminary mass spectrometry (MS) results suggest that MB provides biomarkers for identification of disease such as cancers.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Diagnostic Test - Menstrual Blood Screening Test
The sponsor will be testing women's menstrual blood to investigate the feasibility and efficacy of assessing three early stage cancers via self-collected menstrual blood using FDA approved devices.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Screening and Early Detection of Cancer Through Identification of Novel Female Specific Biomarkers Through Self-Collected Menstrual Blood
common.study.values.clinical-trial-id
NCT03951428
participant.views.study.view.id
e31PAb
